E6(R3) GOOD CLINICAL PRACTICE (GCP)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 6, 2023
June 26, 2023
bfd17ec4-cf4e-4b68-a61c-d3ae1f8a9cd1
Related Documents
Bioanalytical Method Validation for Biomarkers
Guidance DocumentApril 10, 2026Center for Drug Evaluation and Research
E6(R3) Good Clinical Practice (GCP)
Guidance DocumentSeptember 8, 2025Center for Drug Evaluation and Research
Classification Categories for Certain Supplements Under BsUFA III
Guidance DocumentSeptember 8, 2025Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox